Symbol
ANTX on Nasdaq
Investment type
Equity / Common Stock and Warrants
Latest Disclosed Ownership
927K shares
Security Ownership
3.1%

Brii Biosciences Limited ownership in AN2 Therapeutics, Inc. Common Stock and Warrants (ANTX)

2025-02-14 - Brii Biosciences Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 927K shares of AN2 Therapeutics, Inc. Common Stock and Warrants (ANTX). This represents 3.1% percent ownership of the company.